Literature DB >> 991435

Effect of two serotonin antagonists on prolactin and thyrotrophin secretion in man.

C Ferrari, A Paracchi, M Rondena, P Beck-Peccoz, G Faglia.   

Abstract

The effects of serotoninergic blockade on prolactin and thyrotrophin secretion in man was evaluated by determining the basal and TRH-stimulated serum prolactin and TSH concentrations in normal volunteers before and after a 3 days course of cyproheptadine or methergoline administration. Cyproheptadine, a serotonin antagonist with antihistaminic, anticholinergic and antidopaminergic properties as well, did not affect prolactin secretion, while it reduced the serum TSH response to TRH; methergoline, a specific blocker of central serotonin receptors, decreased basal and TRH-induced serum prolactin levels, without affecting TSH secretion. These results support the existence of serotoninergic stimulatory influences on human prolactin release, while suggesting that human TSH secretion is not modulated by serotoninergic inputs.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 991435     DOI: 10.1111/j.1365-2265.1976.tb01987.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  9 in total

1.  The effect of TRH on the release of TSH, PRL and GH in man under basal conditions and following methysergide.

Authors:  R Collu
Journal:  J Endocrinol Invest       Date:  1978-04       Impact factor: 4.256

Review 2.  Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin.

Authors:  M F Scanlon; M Pourmand; A M McGregor; M D Rodriguez-Arnao; K Hall; A Gomez-Pan; R Hall
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

Review 3.  Drug-induced changes in prolactin secretion. Clinical implications.

Authors:  K Hell; H Wernze
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

4.  Inhibition of cimetidine-induced hyperprolactinemia by pretreatment with metergoline.

Authors:  M Iodice; G Lombardi; A P Tommaselli; R Rossi; M Minozzi
Journal:  J Endocrinol Invest       Date:  1981 Jan-Mar       Impact factor: 4.256

5.  Effect of fenfluramine on prolactin and thyroid-stimulating-hormone response to thyrotropin-releasing-hormone in obese and normal women.

Authors:  G Argenio; G Bernini; M S Vivaldi; C Del Corso; F Monzani; L Baschieri; G Bertolozzi; R Santoni; F Franchi; M Luisi
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

6.  Improved oral glucose tolerance following antiserotonin treatment in patients with chemical diabetes.

Authors:  C Ferrari; C Barbieri; R Caldara; V Magnoni; G P Testori; M Romussi
Journal:  Eur J Clin Pharmacol       Date:  1979-07       Impact factor: 2.953

7.  Prolactin secretion in man: a useful tool to evaluate the activity of drugs on central 5-hydroxytryptaminergic neurones. Studies with fenfluramine.

Authors:  A Quattrone; G Tedeschi; U Aguglia; F Scopacasa; G F Direnzo; L Annunziato
Journal:  Br J Clin Pharmacol       Date:  1983-11       Impact factor: 4.335

8.  Effect of metergoline on serum prolactin stimulated by TRH.

Authors:  F Iannotta; G Gadaleta; C Pollini; M P Vettaro
Journal:  J Endocrinol Invest       Date:  1980 Jul-Sep       Impact factor: 4.256

9.  Effects of ritanserin, a novel serotonin-S2 receptor antagonist, on the secretion of pituitary hormones in normal humans.

Authors:  D Tepavcević; Z Giljević; M Korsić; S Halimi; E Suchanek; T Jelić; I Aganović; B Kozić; V Plavsić
Journal:  J Endocrinol Invest       Date:  1994-01       Impact factor: 4.256

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.